Cellulitis syndromes: an update

Int J Antimicrob Agents. 2000 Mar;14(2):113-6. doi: 10.1016/s0924-8579(99)00169-7.

Abstract

Cellulitis is a commonly seen clinical syndrome that is most often associated with beta-haemolytic streptococci and Staphylococcus aureus. Several medical conditions and a variety of procedures can predispose to the development of cellulitis by a common mechanism: venous and lymphatic compromise. The precise pathophysiologic and immunologic details involved in the predisposition to cellulitis remain poorly understood. Therapy is directed at resolution of acute infection and prevention of recurrent episodes of cellulitis.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cellulitis / drug therapy
  • Cellulitis / epidemiology
  • Cellulitis / microbiology*
  • Cellulitis / pathology
  • Child
  • Humans
  • Retrospective Studies
  • Risk Factors
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology*
  • Staphylococcal Infections / pathology
  • Staphylococcus aureus / isolation & purification
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / microbiology*
  • Streptococcal Infections / pathology
  • Streptococcus / isolation & purification

Substances

  • Anti-Bacterial Agents